弘信電子(300657.SZ):深交所恢復對公司資產重組事項的審核
格隆匯5月12日丨弘信電子(300657.SZ)公佈,公司擬通過發行股份及支付現金的方式購買蘇州市華揚電子股份有限公司100%股權,同時擬向不超過35名符合條件的特定投資者發行股份募集配套資金。此次交易構成關聯交易,但不構成重大資產重組。
公司已按相關規定完成了此次交易的加期審計及更新申請材料等工作,並於2022年5月11日向深圳證券交易所恢復本次交易申請文件的審核。
2022年5月12日,公司收到深圳證券交易所的回覆信息,根據《深圳證券交易所創業板上市公司重大資產重組審核規則》第五十一條相關規定,深圳證券交易所同意恢復審核。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.